Paxil Withdrawal: Why It's Often the Hardest SSRI to Stop

Maybe you’ve tried to stop Paxil before and felt dizzy, wired, and not like yourself within a couple of days. Maybe you missed a weekend of doses and had the same experience. You’re not imagining it, and you’re not weak for struggling. Paroxetine is known for being one of the harder antidepressants to come off.

Your brain adapts to an SSRI over months, adjusting to the extra serotonin the drug makes available. When the drug leaves quickly, that adjustment is left without support, and the Paxil prescribing information describes paroxetine as having a half-life of about 21 hours with essentially inactive metabolites. Nothing lingers to soften the drop. Stopping it with precision means controlling how fast levels fall.

The standard advice is to reduce the dose gradually rather than stop abruptly, and that advice rests on solid evidence. In a double-blind interruption trial, people whose paroxetine was secretly swapped for placebo developed new symptoms after the second missed dose, while people on fluoxetine had no significant change. The results are real, and the science is well established.

But a standard taper often isn’t built for how paroxetine clears from the body, and at Siggy we think your plan should be. A paroxetine-specific taper accounts for the drug’s short half-life, its nonlinear drop in levels, and the tablet forms available to reach smaller doses. It aims for the same goal as any taper, stopping without a rough landing, with more precision about where the rough patches usually are. Paxil’s withdrawal pattern follows its pharmacology.

What This Page Covers

• Why Paxil Has This Reputation
• Three Reasons Paxil Is Harder to Stop
• What Paxil Withdrawal Feels Like
• What the Label Says About Tapering
• What the Evidence Says About Slower Tapers
• Getting to Smaller Doses
• Withdrawal or Relapse?

Why Paxil Has This Reputation

The reputation comes from repeated comparisons. A widely cited tapering review summarized reported withdrawal rates of 42% to 100% for paroxetine, compared with 9% to 77% for fluoxetine, and noted that paroxetine symptoms can start within two days.

A randomized trial of 242 people in remission found that a 5 to 8 day interruption caused the most discontinuation symptoms with paroxetine, fewer with sertraline, and the fewest with fluoxetine. More recently, a 2024 meta-analysis of 79 studies listed paroxetine among the antidepressants linked to more severe discontinuation symptoms.

Three Reasons Paxil Is Harder to Stop

The first reason is speed. With a half-life of about 21 hours and no meaningful active metabolites, paroxetine levels fall quickly once doses stop. In the interruption trial, the percentage drop in blood levels was significantly related to new symptoms across all three drugs studied.

The second is paroxetine’s nonlinear kinetics. The label explains that paroxetine saturates CYP2D6, the liver enzyme that helps clear it, so levels don’t track dose in simple proportion. The tapering review notes this pattern predicts disproportionate drops in blood levels as the dose comes down.

The third is less certain. The review’s authors suggest paroxetine’s anticholinergic effects and its modest action on norepinephrine may add to withdrawal, because those systems also have to readjust. That’s a plausible explanation rather than a proven one. Our guide to Paxil dosage covers how these same features shape dose increases.

What Paxil Withdrawal Feels Like

The Paxil label lists symptoms reported after stopping serotonergic antidepressants, particularly after stopping abruptly: dizziness, nausea, sweating, irritability, agitation, anxiety, headache, trouble sleeping, tremor, confusion, low or unstable mood, and sensory disturbances such as electric shock sensations. The same list includes tinnitus, hypomania, and seizures.

Timing is often the giveaway. In the interruption trial, paroxetine symptoms appeared after the second missed dose and grew over the 5 days, along with a measurable drop in daily functioning. If symptoms show up a day or two after a missed dose or a dose cut, withdrawal is the likeliest explanation.

What the Label Says About Tapering

The label recommends reducing the dose gradually rather than stopping abruptly whenever possible. It also describes the taper used in Paxil’s generalized anxiety and PTSD trials: the daily dose was lowered by 10 mg at weekly intervals, then held at 20 mg for 1 week before stopping. Even with that taper, abnormal dreams, paresthesia, and dizziness occurred at least twice as often as with placebo.

The label’s CYP2D6 section adds a detail most people miss. Because paroxetine blocks CYP2D6, drugs such as metoprolol, atomoxetine, venlafaxine, and risperidone may need a dose increase when Paxil is stopped. If you take any of these, ask your prescriber to review them as you taper.

What the Evidence Says About Slower Tapers

Several studies summarized in the tapering review suggest that slower, individualized tapers cause fewer symptoms than the short schedules used in trials:

Approach	Group Studied	Result
10 mg cuts every 2 weeks	Paroxetine users	Withdrawal 4.6%, vs 34% abrupt
Individualized taper, average 38.6 weeks	Paroxetine users	Withdrawal 6%, vs 78% abrupt
Tapering strips to very small doses	1,194 people, most with past withdrawal	71% stopped, median 2 months

These findings come from individual studies gathered in a narrative review, not from a meta-analysis of randomized trials, so they point in a direction rather than proving an ideal schedule. The review’s authors propose hyperbolic tapering, meaning smaller and smaller cuts as the dose gets lower, because the drug’s effect on its target drops off sharply at low doses. They also note a clinical consensus of waiting 1 to 4 weeks between reductions.

Not everyone agrees on how slow is necessary. A 2025 JAMA Psychiatry meta-analysis of randomized trials found average discontinuation symptoms at 1 week were below the threshold for a clinically significant syndrome and questioned the need for routine long tapers. Its authors also noted that most trials followed people for only about 2 weeks, and paroxetine was assessed in just one study in their symptom-scale analysis. Given paroxetine’s track record, we think a cautious, individualized pace is the safer default.

Getting to Smaller Doses

Reaching small doses takes planning, because the available forms are limited. The label says the 10 mg and 20 mg immediate-release tablets are scored, and it lists a 10 mg per 5 mL oral suspension that is not currently marketed. The Paxil CR prescribing information says its extended-release tablets must be swallowed whole, so they can’t be split for smaller steps.

The tapering review notes that liquid formulations may be needed to reach very small doses, which your prescriber and pharmacist can help arrange. It also describes switching to an SSRI with a longer half-life, such as fluoxetine, as a way to make drug levels fall more gradually. Either route is a prescriber decision, and our guide to adjusting an antidepressant dose without losing continuity covers how to keep those changes coordinated.

Withdrawal or Relapse?

Withdrawal and relapse can look alike, and mixing them up leads to bad decisions in both directions. The 2025 meta-analysis found that stopping an antidepressant wasn’t associated with low mood as a discontinuation symptom, and its authors concluded that depression appearing later points to relapse.

A rough guide:

• New dizziness, electric shock sensations, nausea, or irritability within days of a dose change most likely reflects withdrawal.
• Low mood, loss of interest, or hopelessness that builds over weeks most likely reflects the original condition returning.
• Either way, tell your prescriber. The tapering review notes that restarting the drug usually resolves withdrawal symptoms, which makes it possible to pause and then go more slowly.

If you have thoughts of harming yourself, call or text 988. If you’re in immediate danger, call 911.

Gaps between visits are especially hard during a Paxil taper, when symptoms can show up within days and the next visit may be weeks away.

Paxil is harder to stop than most SSRIs because its levels fall fast and unevenly. The label’s short taper is a starting point, and slower, individualized reductions with room to pause appear to cause fewer problems. If you’re weighing whether a different SSRI would be easier to live with long term, our look at SSRI medications compared walks through the options.

Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.

This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication.